Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with a new kind of pump technology in the Twiist device.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

Tandem Diabetes Care (TNDM) and Insulet (PODD) stocks draw outperform ratings at Bernstein as insulin pump makers prepare for ...

Early research shows the CD40L antibody tegoprubart is able to reduce insulin dependence in patients with type 1 diabetes after islet transplants.

"Year to date" sales for 2021, 2022, 2023, and 2024 sales are shown in series at the top of the table and then just below a comparison of 2024 versus 2023 and 2024 versus 2022 is displayed.

Ranked as the Phillies' No. 5 overall prospect, the 18-year-old has impressed people within the organization, and has done enough already to earn a comparison to their franchise legend Carlos Ruiz.

Trump fires back at 'fascist,' 'Hitler' comparisons from Harris, Kelly Former President Trump talks to Fox News' Bill Melugin about the allegations from Vice President Kamala Harris, his ex-chief ...